JAMP-BEZAFIBRATE SR
Identification of Jamp-Bezafibrate Sr
| No description |
Google image searchProduct monograph
Active ingredient
bezafibrate, 400 MG
DIN: 02453312
Dosage form(s): TABLET (EXTENDED-RELEASE)
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 06-APR-2016
ATC:
- C10 — LIPID MODIFYING AGENTS (ATC, ATC/DDD, )
- C10A — LIPID MODIFYING AGENTS, PLAIN (ATC, ATC/DDD)
- C10AB — Fibrates (ATC, ATC/DDD)
- C10AB02 — BEZAFIBRATE (ATC/DDD)
Reference brand drug: Bezalip
Pharmaceutical standard: MFR
